Document Detail


Neonatology in the 1990's: surfactant replacement therapy becomes a reality.
MedLine Citation:
PMID:  2009723     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
It has been more than 35 years since the lung was discovered to be lined with a layer of surface-active material that is important in lung stability and mechanics of respiration. The absence of this "anti-atelectasis" factor was proposed by Avery and Mead in 1959 to be the cause of hyaline membrane disease of premature infants. An indepth historical review of pulmonary surfactant by Tierney was recently published. In the years since 1959, there has been an exhaustive amount of research aimed at elucidating the structure and function of pulmonary surfactant, the ultimate goal being a safe and effective exogenous surfactant for the treatment of the Respiratory Distress Syndrome (RDS). The days of surfactant research are far from over, but the era of surfactant replacement therapy is now upon us. The practitioner needs to be knowledgeable about surfactant and aware of his or her role in surfactant therapy for premature infants. The following is intended to clarify some of the important issue of surfactant replacement.
Authors:
D D Berry
Related Documents :
15143473 - Association between common toll-like receptor 4 mutations and severe respiratory syncyt...
11338223 - Acute respiratory failure and oxygen therapy.
17675023 - Electrocortical functional connectivity in infancy: response to body tilt.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical pediatrics     Volume:  30     ISSN:  0009-9228     ISO Abbreviation:  Clin Pediatr (Phila)     Publication Date:  1991 Mar 
Date Detail:
Created Date:  1991-05-03     Completed Date:  1991-05-03     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0372606     Medline TA:  Clin Pediatr (Phila)     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  167-72     Citation Subset:  AIM; IM    
Affiliation:
Department of Pediatrics, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27103.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Infant, Newborn
Neonatology / trends
Pulmonary Surfactants / analysis,  therapeutic use*
Respiratory Distress Syndrome, Newborn / drug therapy
Chemical
Reg. No./Substance:
0/Pulmonary Surfactants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Klinefelter syndrome: the need for early identification and treatment.
Next Document:  Recombinant interleukin-2: a biological response modifier.